| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-12 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.43 | 1e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.39 | 1e-11 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.36 | 5e-11 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.4 | 5e-11 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-08 |